The MES TimesThe H1-X could be on the market by 2025 if everything goes according to plan, including flight testing and FAA certification.
Teif LabExcited to present our new preprint on nucleosome reorganisation in breast cancer! https://www.biorxiv.org/content/10.1101/2023.04.17.537031v1 It's a large project, mapping nucleosome repositioning in paired normal and tumour tissues and cell-free DNA from the same patients #TFbinding #cfDNA #H1X #5mC #LiquidBiopsy
